Greenville, SC – July 22, 2025 – Broadstreet Partners is pleased to announce its representation of Samaritan Biologics in securing a lease for a new state-of-the-art manufacturing facility at 215 Innovation Drive, Greenville, SC. This facility, encompassing 11,000 square feet, is situated within Flex Lab One at the Clemson University International Center for Automotive Research (CU-ICAR).
Samaritan Biologics specializes in the development, manufacturing and distribution of human amniotic products for wound care and surgical applications. This new facility will process human cellular tissue products.
“We are thrilled to support Samaritan Biologics in their expansion efforts,” said John Parker, Broker/Partner at Broadstreet Partners. “This new facility will not only enhance their operational capabilities but also contribute to the growing biotech ecosystem in Greenville.”
Samaritan Biologics is committed to advancing the field of regenerative medicine, and this facility will play a crucial role in their mission to deliver innovative cellular therapies.
For more information about Samaritan Biologics and their commitment to healthcare innovation, please visit www.samaritanbiologics.com.
